• 제목/요약/키워드: Interstitial pneumonitis

검색결과 57건 처리시간 0.023초

Cyclosporin 치료로 호전된 비특이성 간질성 폐렴 1예 (A Case of Nonspecific Interstitial Pneumonitis Improved After Cyclosporin Therapy)

  • 안상미;조숙경;임승관;송영준;최준혁;신승수;오윤정;최영화;박광주;황성철
    • Tuberculosis and Respiratory Diseases
    • /
    • 제55권6호
    • /
    • pp.631-635
    • /
    • 2003
  • 비특이성 간질성 폐렴에서 대개의 경우 스테로이드 치료로 호전지만 스테로이드 저항성 인 경우 여러 가지 면역 억제제가 이차 약제로 치료에 시도되고 있으며 본 증례에서는 cyclosprin을 이차약제로 사용해서 좋은 치료 효과를 얻었기에 문헌 고찰과 함께 보고 하는 바이다.

페그-인터페론과 리바비린 병합치료 중 발생한 간질성 폐렴 및 범혈구 감소증 1예 (A Case of Interstitial Pneumonitis and Pancytopenia Following the Combination Therapy of Pegylated Interferon and Ribavirin)

  • 서지현;한성환;이지은;한진형;김경묵;김도형;김윤섭;박재석;지영구
    • Tuberculosis and Respiratory Diseases
    • /
    • 제70권1호
    • /
    • pp.69-73
    • /
    • 2011
  • The combination therapy of pegylated interferon and ribavirin is the mainstay of treatment for chronic hepatitis C patients. Anti-viral therapy is commonly associated with side effects such as headache, fever, myalgia, and arthralgia. However, anti-viral therapy can continue because these side effects are mostly mild and can be improved with supportive management. Anti-viral therapy should be stopped promptly if serious side effects, such as interstitial pneumonitis or hemolytic anemia occur, although those serious side effects are rare. There were a few case reports of interferon-related interstitial pneumonitis worldwide. In Korea, one atypical case report of interstitial pneumonitis has been reported, which followed the combination therapy of interferon-alpha and ribavirin in a patient with chronic hepatitis C. We present a case of interstitial pneumonitis and pancytopenia following the combination therapy of pegylated interferon and ribavirin in a patient with chronic hepatitis C.

만성 C형 간염 환자에서 Interferon-${\alpha}$를 투여중 발생한 간질성 폐렴 1예 (A Case of Interstitial Pneumonitis developed by Interferon-${\alpha}$ Treatment for Chronic Hepatitis C)

  • 윤종구;안중현;고승현;이현승;권순석;김영균;문화식;박성학;송정섭
    • Tuberculosis and Respiratory Diseases
    • /
    • 제43권4호
    • /
    • pp.637-644
    • /
    • 1996
  • 만성 C형 간염환자에서 IFN으로 치료중에 발생된 간질성 폐렴은 매우 드물고 아직까지국내에는 보고된 바 없었다. 저자들은 만성 C형 간염환자가 IFN-${\alpha}$를 투여받던 중에 기침과 호흡곤란을 주소로 내원하여 간질성 폐렴으로 진단된 1예를 경험하였기에 문헌고찰과 함께 보고하는 바이다.

  • PDF

Interstitial Pneumonitis를 동반한 Sj$\ddot{o}$gren's 증후군 1예 (A Case of Sj$\ddot{o}$gren's Syndrome with Intersititial Pneumonitis)

  • 박준영;이규락;이상무;김현태;어수택;정연태;김용훈;박춘식;진소영
    • Tuberculosis and Respiratory Diseases
    • /
    • 제39권4호
    • /
    • pp.348-354
    • /
    • 1992
  • Sj$\ddot{o}$gren's syndrome (SS) is an immunologic disorder characterized by progressive destruction of the exocrine glands due to infiltration of lymphocyte resulting in mucosal and conjunctival dryness accompanied by a variety of autoimmune phenomena. And SS is divided into primary and secondary by accompanying collagen vascular diseases. In Korea, only a few cases of primary SS and primary SS with interstitial pneumonitis have been documented. Recently we experinced a suspected case of primary SS with interstitial pneumonitis diagnosed by sublabial and open lung biopsy, Schirmer's test and slit lamp test.

  • PDF

Current Diagnosis and Management of Hypersensitivity Pneumonitis

  • Leone, Paolo Maria;Richeldi, Luca
    • Tuberculosis and Respiratory Diseases
    • /
    • 제83권2호
    • /
    • pp.122-131
    • /
    • 2020
  • Hypersensitivity Pneumonitis (HP) one of the most common interstitial lung diseases (ILDs) is characterized by exposure to an inhaled inciting antigen that leads to a host immunologic reaction determining interstitial inflammation and architectural distortion. The underlying pathogenetic mechanisms are unclear. The absence of international shared diagnostic guidelines and the lack of a "gold-standard" test for HP combined with the presence of several clinical and radiologic overlapping features makes it particularly challenging to differentiate HP from other ILDs, also in expert contests. Radiology is playing a more crucial role in this process; recently the headcheese sign was recognized as a more specific for chronic-HP than the extensive mosaic attenuation. Several classification proposals and diagnostic models have been advanced by different groups, with no prospective validation. Therapeutic options for HP have been limited to antigen avoidance and immunosuppressant drugs over the last decades. Several questions about this condition remain unanswered and there is a need for more studies.

Leflunomide로 치료중인 류마티스 관절염 환자에서 발생한 간질성 폐렴 1예 (A Case of Interstitial Pneumonitis in a Patient with Rheumatoid Arthritis Treated with Leflunomide)

  • 신아영;김승수;김경희;주일남;고혁재
    • Tuberculosis and Respiratory Diseases
    • /
    • 제66권6호
    • /
    • pp.477-481
    • /
    • 2009
  • Leflunomide는 항류마티스 약제로 최근 류마티스 관절염 치료에 효과적으로 사용되고 있다. 최근 본 약제로 인한 간질성 폐렴이 일본과 한국에서 서구에서보다 많이 보고되고 있으며 종종 사망하는 경우도 보고되고 있다. 저자들은 25세 여자에서 Methotrexate와 Leflunomide의 병합요법 중 발생한 간질성 폐렴을 진단하였고 Methylprednisolone과 Cholestyramine을 조기 투여하여 효과적으로 치료하였기에 문헌 고찰과 함께 보고하는 바이다.

Bronchiolitis Interstitial Pneumonitis 1예 (A Case of Bronchiolitis Interstitial Pneumonitis)

  • 지수영;유경호;임대훈;신홍준;반희정;오인재;권용수;김규식;임성철;김영철;최유덕;송상윤;선현주
    • Tuberculosis and Respiratory Diseases
    • /
    • 제67권4호
    • /
    • pp.364-368
    • /
    • 2009
  • Bronchiolitis interstitial pneumonitis (BIP), an unclassified and newly described interstitial pneumonia, has a combined feature of prominent bronchiolitis, interstitial inflammation, and fibrosis. It is distinct from bronchiolitis obliterans or bronchiolitis obliterans organizing pneumonia (BOOP). BIP has a better prognosis than common cases of interstitial pneumonia. However, BIP has a poorer prognosis than BOOP. BIP's response to corticosteroids is not as successful as BOOP's response to this treatment. We encountered the case of a 31-year-old woman with BIP with an initial presentation of dyspnea and a cough that had lasted for 3 months. The patient's chest CT scan demonstrated patchy ground glass opacities and multiple ill-defined centrilobular nodules in both lungs, suggesting military tuberculosis or nontuberculous mycobacterial infection. A video-assisted thoracoscopic lung biopsy resulted in the diagnosis of BIP. Clinical symptoms, pulmonary lesions, and pulmonary function tests were improved after oral glucocorticoid therapy.

황련으로 만든 한약 복용 후 발생한 급성 간손상을 동반한 간질성 폐렴 1예 (A Case of Interstitial Pneumonitis with Acute Live Injury Caused by Herbal Medicine Made from Golden Thread)

  • 전병우;김다민;박지현;정현애;송림화;한정호;정만표
    • Tuberculosis and Respiratory Diseases
    • /
    • 제71권6호
    • /
    • pp.470-475
    • /
    • 2011
  • So far more than 350 drugs have been reported to be the cause for lung injury and the incidence tends to increase. Although infiltrative lung disease is the most common pattern of drug-induced lung injury, it can appear in the form of alveolar changes, vasculitis and other injury. Herbal medicine also has been known as a cause for interstitial pneumonitis, but it is difficult to identify the key herbal medicine because of the complex components of the contents. Till date, there is no report of pneumonitis caused by golden thread. Here we report a case of a 54-year-old male who developed interstitial pneumonitis with acute liver injury caused by herbal medicine made from golden thread.

Mesalizine-Induced Acute Pancreatitis and Interstitial Pneumonitis in a Patient with Ulcerative Colitis

  • Chung, Min Jae;Lee, Jae Hee;Moon, Kyung Rye
    • Pediatric Gastroenterology, Hepatology & Nutrition
    • /
    • 제18권4호
    • /
    • pp.286-291
    • /
    • 2015
  • Ulcerative colitis (UC) is a chronic idiopathic inflammatory bowel disease. Mesalizine for the first-line therapy of UC has adverse effects include pancreatitis, pneumonia and pericarditis. UC complicated by two coexisting conditions, however, is very rare. Moreover, drug-related pulmonary toxicity is particularly rare. An 11-year-old male patient was hospitalized for recurring upper abdominal pain after meals with vomiting, hematochezia and exertional dyspnea developing at 2 weeks of mesalizine therapy for UC. The serum level of lipase was elevated. Chest X-ray and thorax computed tomography showed interstitial pneumonitis. Mesalizine was discontinued and steroid therapy was initiated. Five days after admission, symptoms were resolved and mesalizine was resumed after a drop in amylase and lipase level. Symptoms returned the following day, however, accompanied by increased the serum levels of amylase and lipase. Mesalizine was discontinued again and recurring symptoms rapidly improved.

가습기 폐질환(Humidifier Lung)의 환경적 원인 인자 고찰 (Review of Humidifier Lung Cases Caused by Use of Humidifier - Focusing on Probable Environmental Causal Agents -)

  • 박동욱
    • 한국환경보건학회지
    • /
    • 제39권2호
    • /
    • pp.105-116
    • /
    • 2013
  • Background: In Korea, there is low awareness of the respiratory health problems caused by the use of humidifiers, leading to a lack of governmental measures. Objectives: The objectives of this study were to review cases of varying degrees of humidifier lung and fever in connection with the use of humidifiers and to summarize the probable environmental agents causing these cases. Methods: We searched all articles reporting on humidifier lung, humidifier fever, and humidifier diseases caused by the use of a humidifier both at home and in the workplace. Results: We summarized a number of cases of varying degrees of respiratory diseases resulting from inhalation of water mist of humidifiers containing various species of bacteria and fungi and their toxins. Type of respiratory disease connected with humidifier lung includes interstitial pneumonitis, hypersensitivity pneumonitis, fever and several respiratory symptoms. Non-tuberculous mycobacteria (NTM), Actinomycetes, endotoxins and contaminated humidifier water were the most commonly suspected probable environmental agents causing humidifier lung. In Korea, the use of humidifier biocide is suspected as a likely cause of fatal lung injury including death and lung transplantation. Conclusion: Governmental policy should be devised and measures including a national surveillance system should be taken to prevent humidifier lung caused by the use of humidifiers.